BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32251807)

  • 21. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature.
    Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG
    Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy.
    Qian L; Zhou C; Shen J; Cen J; Yin W
    Oncotarget; 2016 May; 7(18):25783-90. PubMed ID: 27029056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary central nervous system lymphoma.
    Batchelor TT
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):379-385. PubMed ID: 27913504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
    Furst T; Hoffman H; Chin LS
    J Neurosurg Sci; 2024 Feb; 68(1):44-50. PubMed ID: 31601065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.
    Kreisl TN; Panageas KS; Elkin EB; Deangelis LM; Abrey LE
    Leuk Lymphoma; 2008 Sep; 49(9):1710-6. PubMed ID: 18661394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of treatment in older adults with primary central nervous system lymphoma.
    Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
    Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy is effective as early treatment for primary central nervous system lymphoma.
    Boiardi A; Silvani A; Pozzi A; Fariselli L; Broggi G; Salmaggi A
    J Neurol; 1999 Jan; 246(1):31-7. PubMed ID: 9987711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of genomic alterations in primary central nervous system lymphomas.
    Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
    J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
    Provencher S; Ferlay C; Alaoui-Slimani K; Devidas A; Lepretre S; de Prijck B; Sebban C; de la Fouchardiere A; Chassagne-Clement C; Ketterer N; Thyss A; Delannoy A; Tilly H; Biron P; Blay JY; Ghesquières H
    Hematol Oncol; 2011 Mar; 29(1):10-6. PubMed ID: 21381074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients.
    Barakat M; Albitar M; Whitney R; Abdulhaq H
    Cancer Treat Res Commun; 2021; 27():100310. PubMed ID: 33581493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
    Cheng G; Zhang J
    Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
    Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
    Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
    Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
    Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
    Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
    Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary central nervous system lymphoma: a report of 28 patients].
    Hu Y; Feng FY; Shi YK; Zhou LQ; Gu DZ; Wang QL
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):375-8. PubMed ID: 15312352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma.
    Ishikawa H; Hasegawa M; Tamaki Y; Hayakawa K; Akimoto T; Sakurai H; Mitsuhashi N; Niibe H; Tamura M; Nakano T
    Jpn J Clin Oncol; 2003 Sep; 33(9):443-9. PubMed ID: 14594937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.